A Phase 3, Open-Label Period Followed by a Randomized, Double-blind, Placebo-controlled Study of the Analgesic Efficacy of Extended-release Hydrocodone/Acetaminophen (Vicodin CR) Compared to Placebo in Subjects With Chronic Low Back Pain
Phase of Trial: Phase III
Latest Information Update: 27 Dec 2013
At a glance
- Drugs Hydrocodone/paracetamol (Primary)
- Indications Back pain
- Focus Registrational; Therapeutic Use
- Sponsors Abbott Laboratories; AbbVie
- 05 Nov 2010 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 15 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.